Identification of metabolic phenotypes in childhood obesity by 1H NMR metabolomics of blood plasma

Liene Bervoets, Guy Massa, Wanda Guedens, Gunter Reekmans, Jean-Paul Noben, Peter Adriaensens, Liene Bervoets, Guy Massa, Wanda Guedens, Gunter Reekmans, Jean-Paul Noben, Peter Adriaensens

Abstract

Aim: To identify the plasma metabolic profile associated with childhood obesity and its metabolic phenotypes.

Materials & methods: The plasma metabolic profile of 65 obese and 37 normal-weight children was obtained using proton NMR spectroscopy. NMR spectra were rationally divided into 110 integration regions, which reflect relative metabolite concentrations, and were used as statistical variables.

Results: Obese children show increased levels of lipids, N-acetyl glycoproteins, and lactate, and decreased levels of several amino acids, α-ketoglutarate, glucose, citrate, and cholinated phospholipids as compared with normal-weight children. Metabolically healthy children show lower levels of lipids and lactate, and higher levels of several amino acids and cholinated phospholipids, as compared with unhealthy children.

Conclusion: This study reveals new valuable findings in the field of metabolomics and childhood obesity. Although validation should be performed, the proof of principle looks promising and justifies a deeper investigation of the diagnostic possibilities of proton NMR metabolomics in follow-up studies. Trial registration: NCT03014856. Registered January 9, 2017.

Keywords: N-acetyl glycoproteins; NMR spectroscopy; amino acids; childhood obesity; metabolic syndrome; metabolically healthy obesity; metabolomics; multivariate analysis; obesity; phospholipids.

Conflict of interest statement

Financial & competing interests disclosure This study is part of the Limburg Clinical Research Program (LCRP), supported by the foundation Limburg Sterk Merk, province of Limburg, Flemish government, Hasselt University, Ziekenhuis Oost-Limburg and Jessa Hospital. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Figures

Figure 1. . Discrimination between OB and…
Figure 1.. Discrimination between OB and NW based on the 1H-NMR-derived metabolic phenotype of blood plasma.
OPLS-DA score plot (A) and S-line plot (B) obtained for the OB (▴) and NW (○) children and adolescents. Each participant is represented by its metabolic profile and visualized as a single symbol of which the location is determined by the contributions of the 110 variables in the 1H NMR spectrum. The OPLS-DA score plot (LV = 3) shows the first predictive component (t[1]P: 26.1%), explaining the variation between the groups, versus the first orthogonal component (t[1]O: 53.4%) that explains the variation within the groups. The OPLS-DA S-line plot visualizes differences between OB patients (positive) and NW controls (negative). The left y-axis represents p(ctr)[1], the covariance between a variable and the classification score. It indicates if an increase or decrease of a variable is correlated to the classification score. The magnitude of the covariance is however difficult to interpret since covariance is scale dependent. This means that a high value for the covariance does not necessary imply a strong correlation, as the covariance is also influenced by the intensity of the signal with respect to the noise level. Therefore this measure will likely indicate variables with large signal intensities. On the right y-axis, p(corr)[1] is the correlation coefficient between a variable and the classification score, for example, the normalized covariance. It gives a linear indication of the strength of the correlation. As the correlation is independent of the intensity of the variable, it will be a better measure for the reliability of the variable in the classification process. In Figure 1B, the red color stands for the highest absolute value of the correlation coefficient. Strongly discriminating variables have a large intensity and large reliability. NW: Normal-weight; OB: Overweight or obese; OPLS-DA: Orthogonal partial least square discriminant analysis.
Figure 2. . Discrimination between MHO and…
Figure 2.. Discrimination between MHO and MUO based on the 1H-NMR-derived metabolic phenotype of blood plasma.
OPLS-DA score plot (A) and S-line plot (B) obtained for the MHO (△) and MUO (•) children and adolescents. Each participant is represented by its metabolic profile and visualized as a single symbol of which the location is determined by the contributions of the 110 variables in the 1H NMR spectrum. The OPLS-DA score plot (LV = 2) shows the first predictive component (t[1]P: 38.3%), explaining the variation between the groups, versus the first orthogonal component (t[1]O: 49.4%) that explains the variation within the groups. The OPLS-DA S-line plot visualizes differences between MHO (negative) and MUO (positive) subjects. The left y-axis represents p(ctr)[1], the covariance between a variable and the classification score. The right y-axis presents p(corr)[1], the correlation coefficient between a variable and the classification score, giving a linear indication of the strength of the correlation. The red color stands for the highest absolute value of the correlation coefficient. Strongly discriminating variables have a large intensity and large reliability. MHO: Metabolically healthy obese; MUO: Metabolically unhealthy obese; OPLS-DA: Orthogonal partial least square discriminant analysis.

References

    1. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–781.
    1. Lakshman R, Elks CE, Ong KK. Childhood obesity. Circulation. 2012;126(14):1770–1779.
    1. Biro FM, Wien M. Childhood obesity and adult morbidities. Am. J. Clin. Nutr. 2010;91(5):S1499–S1505.
    1. Spruijt-Metz D. Etiology, treatment and prevention of obesity in childhood and adolescence: a decade in review. J. Res. Adolesc. 2011;21(1):129–152.
    1. Bervoets L, Massa G. Classification and clinical characterization of metabolically “healthy” obese children and adolescents. J. Pediatr. Endocrinol. Metab. 2016 In press.
    1. Prince RL, Kuk JL, Ambler KA, Dhaliwal J, Ball GD. Predictors of metabolically healthy obesity in children. Diabetes Care. 2014;37(5):1462–1468.
    1. Dona AC, Jimenez B, Schafer H, et al. Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping. Anal. Chem. 2014;86(19):9887–9894.
    1. Holmes E, Wilson ID, Nicholson JK. Metabolic phenotyping in health and disease. Cell. 2008;134(5):714–717.
    1. Zhang A, Sun H, Wang X. Power of metabolomics in biomarker discovery and mining mechanisms of obesity. Obes. Rev. 2013;14(4):344–349.
    1. Butte NF, Liu Y, Zakeri IF, et al. Global metabolomic profiling targeting childhood obesity in the Hispanic population. Am. J. Clin. Nutr. 2015;102(2):256–267.
    1. Perng W, Gillman MW, Fleisch AF, et al. Metabolomic profiles and childhood obesity. Obesity (Silver Spring) 2014;22(12):2570–2578.
    1. Mihalik SJ, Michaliszyn SF, De Las Heras J, et al. Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation. Diabetes Care. 2012;35(3):605–611.
    1. Wahl S, Yu Z, Kleber M, et al. Childhood obesity is associated with changes in the serum metabolite profile. Obes. Facts. 2012;5(5):660–670.
    1. Louis E, Adriaensens P, Guedens W, et al. Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types? Ann. Oncol. 2016;27(1):178–184.
    1. Hart CD, Vignoli A, Tenori L, et al. Serum metabolomic profiles identify ER-Positive early breast cancer patients at increased risk of disease recurrence in a multicenter population. Clin. Cancer Res. 2017;23(6):1422–1431.
    1. Dumas ME, Maibaum EC, Teague C, et al. Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP study. Anal. Chem. 2006;78(7):2199–2208.
    1. Lindon JC, Nicholson JK. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu. Rev. Anal. Chem. (Palo Alto Calif.) 2008;1:45–69.
    1. Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr. Obes. 2012;7(4):284–294.
    1. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch. Dis. Child. 1970;45(239):13–23.
    1. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch. Dis. Child. 1969;44(235):291–303.
    1. Falkner B, Daniels SR. Summary of the fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Hypertension. 2004;44(4):387–388.
    1. Zimmet P, Alberti KG, Kaufman F, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr. Diabetes. 2007;8(5):299–306.
    1. Bervoets L, Louis E, Reekmans G, et al. Influence of preanalytical sampling conditions on the 1H NMR metabolic profile of human blood plasma and introduction of the Standard PREanalytical Code used in biobanking. Metabolomics. 2015;11:1197–1207.
    1. Louis E, Adriaensens P, Guedens W, et al. Detection of lung cancer through metabolic changes measured in blood plasma. J. Thorac. Oncol. 2016;11(4):516–523.
    1. Louis E, Bervoets L, Reekmans G, et al. Phenotyping human blood plasma by 1H-NMR: a robust protocol based on metabolite spiking and its evaluation in breast cancer. Metabolomics. 2015;11(1):225–236.
    1. Bervoets L, Massa G, Guedens W, Louis E, Noben JP, Adriaensens P. Metabolic profiling of Type 1 diabetes mellitus in children and adolescents: a case-control study. Diabetol. Metab. Syndr. 2017;9:48.
    1. Eriksson L, Byrne T, Johansson E, Trygg J, Vikström C. Multi- and Megavariate Data Analysis: Basic Principles and Applications (3rd Ed.) Umetrics Academy; Umea, Sweden: 2013. p. 521.
    1. Abu Bakar MH, Sarmidi MR, Cheng KK, et al. Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes. Mol. Biosyst. 2015;11(7):1742–1774.
    1. Reinehr T, Wolters B, Knop C, et al. Changes in the serum metabolite profile in obese children with weight loss. Eur. J. Nutr. 2015;54(2):173–181.
    1. Ferrier DR. In: Lippincott's Illustrated Reviews: Biochemistry (6th Ed.) Harvey RA, editor. Walters Kluwer; PA, USA: 2014.
    1. He Q, Ren P, Kong X, et al. Comparison of serum metabolite compositions between obese and lean growing pigs using an NMR-based metabonomic approach. J. Nutr. Biochem. 2012;23(2):133–139.
    1. Patti ME, Virkamaki A, Landaker EJ, Kahn CR, Yki-Jarvinen H. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes. 1999;48(8):1562–1571.
    1. Kaneto H, Xu G, Song KH, et al. Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress. J. Biol. Chem. 2001;276(33):31099–31104.
    1. Obici S, Wang J, Chowdury R, et al. Identification of a biochemical link between energy intake and energy expenditure. J. Clin. Invest. 2002;109(12):1599–1605.
    1. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 1999;340(6):448–454.
    1. Bell JD, Brown JC, Nicholson JK, Sadler PJ. Assignment of resonances for ‘acute-phase’ glycoproteins in high resolution proton NMR spectra of human blood plasma. FEBS Lett. 1987;215(2):311–315.
    1. Schipper HS, Nuboer R, Prop S, et al. Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14++ monocytes. Diabetologia. 2012;55(10):2800–2810.
    1. Daniels SR. Lipid concentrations in children and adolescents: it is not all about obesity. Am. J. Clin. Nutr. 2011;94(3):699–700.
    1. Soininen P, Kangas AJ, Wurtz P, et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst. 2009;134(9):1781–1785.
    1. Cali AM, Zern TL, Taksali SE, et al. Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state. Diabetes Care. 2007;30(12):3093–3098.
    1. Pietilainen KH, Rog T, Seppanen-Laakso T, et al. Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol. 2011;9(6):e1000623.
    1. Feng RN, Niu YC, Sun XW, et al. Histidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome: a randomised controlled trial. Diabetologia. 2013;56(5):985–994.
    1. Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9(4):311–326.

Source: PubMed

3
Abonnieren